Skip to main content
4 Belinder Road
Gaithersburg, MD 20878
Phone 301.977.3600

Reports & Presentations

Jointly produced by several national addiction experts, this comprehensive report contains recommendations and evidence-based strategies for investment of litigation settlement funds to end the opioid crisis and mitigate future harms.

This report was designed to support and empower state and local officials in making critical allocation decisions and consolidates the best research evidence to provide recommendations for high-impact investments that will improve the addiction treatment system, strengthen prevention and harm reduction programming, and address substance use disorder within the criminal justice system. In addition to outlining the scientific support for each recommendation, the authors include detailed guidance related to economic impacts and policy considerations.

This presentation was delivered at the Integrating Primary and Behavioral Health Care Through the Lens of Prevention Conference on November 15, 2018 in conjunction with the Education Development Center (EDC). Carnevale Associates and EDC present on the changing nature of substance use prevention; the shifting health care landscape; health care payers, payment vehicles and service delivery models; and the implications of health care financing for prevention partnerships at both the individual and population health levels.

This presentation was delivered at the National Prevention Network (NPN) Conference on August 28, 2018 in conjunction with the Education Development Center (EDC). Carnevale Associates and EDC present emerging trends in opioids (including heroin and fentanyl), cocaine, methamphetamine, and marijuana -- particularly in the context of substance use prevention.

This presentation was delivered at the National Prevention Network (NPN) Conference on August 29, 2018 in conjunction with the Education Development Center (EDC). Carnevale Associates and EDC outline the state of cannabis laws at the state and local level, review pros and cons of the regulatory options available to states, consider differences between the tobacco and alcohol models of for-profit regulation, and ultimately review the implications of state-level cannabis legalization for substance use prevention professionals.

On April 7, 2016, the Public Policy Institute of California (PPIC), released a report titled "Regulating Marijuana in California." Authored by Patrick Murphy and John Carnevale, the report concludes that, if California legalizes recreational marijuana, the state should develop a single highly regulated marijuana market-- for medical and recreational uses. The report analyzes the regulatory approaches taken by Washington and Colorado-- the first two states to legalize recreational marijuana-- to help California learn from their experiences.

This whitepaper examines the opportunities and challenges presented by the Affordable Care Act (the ACA) for criminal justice reentry.

An estimated 6.89 million individuals were under the supervision of adult correctional systems in 2013, 4.75 million under community supervision, 1.57 million in prison, and roughly 731,000 housed in local jails on any given day. With millions more passing through local jails every year, people flowing through the criminal justice system are less likely to have health coverage and often have significant healthcare needs. Yet while the criminal justice system accounts for only a small percentage of the U.S. population, an estimated 14% of residents with HIV, 33% of those with Hepatitis-C, and 40% of those with tuberculosis pass through correctional facilities, while 40% of men and nearly 60% of women in jail have at least one chronic health condition. According to numerous studies, healthcare disruptions when these individuals reenter the community have been found to lead to increased rates or re-incarceration, worse healthcare outcomes, and more costly care.

Delivered at the 2013 Utah Valley University Conference on Addiction, this presentation examines the non-medical use of prescription drugs and the Office of National Drug Control Policy's (ONDCP) strategies to curtail prescription drug abuse, notably examining Prescription Drug Monitoring Programs (PMPs) and the Drug Enforcement Administration's (DEA) Proposed Rule governing prescription drug takeback programs.

Using information retained by the Treasury Enforcement Communications System (TECS) and other sources, Carnevale Assoiciates worked closely with the SAI, the U.S. Department of Justice, National Drug Intelligence Center, and the Department of Homeland Security, Office of Customs and Border Protection, to develop a method for monitoring the quantity of drug-related bulk cash exiting the country each year at ports of entry on the Southwest Border of the United States.

Materials associated with this work are currently FOUO.

This presentation, delivered at the National Conference of Insurance Legislators' (NCOIL) annual meeting in Point Clear, Alabama, examines the non-medical use of prescription drugs (particularly opioids), the consequences of non-medical use, and the strategies currently available to combat such use.

Delivered at the 51st Regular Session of the Inter-American Drug Abuse Control Commission (CICAD) in 2012, this presentation explores the importance and relevance of evidence-based drug policy particularly: formulation, monitoring, and evaluation. The presentation also examines how this policymaking method is more efficient than methods that do not utilize such evidence. The presentation considers general principles of policymaking and explains how to apply those principles to a national drug policy, linking those principles to CICAD's policy framework, which is comprised of: Community, Strategy, Evaluation, and Budget.